AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 9890315
Drug: prednisolone, azathioprine,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: prednisolone, azathioprine, heparin‐warfarin, and dipyridamole for 2 yr (group 1)
Trial: 9890315
Drug: heparin‐warfarin and
FDA approved: no
EMA approved: no
PMDA approved: no
Description: heparin‐warfarin and dipyridamole for 2 yr (group 2)
Trial: 1835989
Drug: Lymphoblastoid or
RxNorm normalized name: Medicated Pad or Tape
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lymphoblastoid or recombinant alpha-interferon (2-6 months, ≥2 mega-units thrice weekly)
Trial: 1835989
Drug: Lymphoblastoid or
RxNorm normalized name: Medicated Pad or Tape
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lymphoblastoid or recombinant alpha-interferon (9-18 months, variable dose)
Trial: 30661255
Drug: cilofexor 100
RxNorm normalized name: Cilofexor
DrugBank: Cilofexor (DB15168)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: cilofexor 100 mg
Trial: 30661255
Drug: cilofexor 30
RxNorm normalized name: Cilofexor
DrugBank: Cilofexor (DB15168)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: cilofexor 30 mg
Trial: 27371977
Drug: Long-lasting insecticidal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Long-lasting insecticidal nets plus topical repellent (picaridin KBR3023)
Trial: 18307459
Drug: Multiple daily
RxNorm normalized name: Multivitamin Oral Tablet [MULTIPLE DAILY W/BETA]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multiple daily injections (MDI) with glargine
Trial: 12629071
Drug: Low-fixed dose,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-fixed dose, 235 MBq
Trial: 12629071
Drug: High-fixed dose,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-fixed dose, 350 MBq
Trial: 12629071
Drug: Low-adjusted dose,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-adjusted dose, 2.96 MBq (80 micro Ci)/g thyroid adjusted for 24 h radioiodine uptake
Trial: 12629071
Drug: High-adjusted dose,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-adjusted dose, 4.44 MBq (120 micro Ci)/g thyroid adjusted for 24 h radioiodine uptake
Trial: 12629071
Drug: Fixed dose
RxNorm normalized name: Humalog Mix
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fixed dose methods
Trial: 12629071
Drug: Adjusted dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adjusted dose methods
Trial: 8853810
Drug: Heparin-coated CPB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heparin-coated CPB circuit (Duraflo II)
Trial: 6228500
Drug: Ticlopidine (250
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ticlopidine (250 mg t.i.d.)
Trial: 31983105
Drug: Concomitant chemotherapy
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Concomitant chemotherapy with IMRT
Trial: 31983105
Drug: Concomitant chemotherapy
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Concomitant chemotherapy with 3DCRT
Trial: 10537435
Drug: AHA step
RxNorm normalized name: PostDay One-Step
DrugBank: Levonorgestrel (DB00367)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: AHA step II diet plus simvastatin (mean dosage 8.11 mg/day)
Trial: 7703634
Drug: Replenishing Qi
RxNorm normalized name: San Qi Root
DrugBank: Panax notoginseng root (DB14304)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Replenishing Qi and Invigorating Spleen (RQIS) combined with chemotherapy
Trial: 3131389
Drug: Adjunctive lithium
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adjunctive lithium
Trial: 29512900
Drug: Dasatinib at
RxNorm normalized name: Dasatinib
DrugBank: Dasatinib (DB01254)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Dasatinib at 50 mg/m² and crizotinib at 215 mg/m² once daily
Trial: 29512900
Drug: Dasatinib at
RxNorm normalized name: Dasatinib
DrugBank: Dasatinib (DB01254)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Dasatinib at 50 mg/m² and crizotinib at 130 mg/m² or 100 mg/m² twice daily
Trial: 26900386
Drug: L-citrulline 2.4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-citrulline 2.4 g/day for 7 days, then 2.4 g 1 hour before cycling trial
Trial: 26900386
Drug: L-citrulline 2.4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-citrulline 2.4 g/day
Trial: 24299932
Drug: Prophylactic variable
RxNorm normalized name: polylactic acid-polyglycolic acid copolymer
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prophylactic variable rate phenylephrine infusion starting at 0.75 μg/kg/min (group P)
Trial: 24299932
Drug: Infusion of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Infusion of normal saline (group S)
Trial: 20371662
Drug: Vandetanib 100
RxNorm normalized name: vandetanib 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vandetanib 100 mg/d
Trial: 18759067
Drug: 15 mg/day
RxNorm normalized name: Climara Pro 0.045/0.015 MG/Day Weekly Transdermal System
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15 mg/day zinc sulfate for 2 weeks
Trial: 18759067
Drug: 0.625 mg
RxNorm normalized name: estrone 0.625 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.625 mg estrogen + 5 mg medroxyprogesterone acetate/day for 2 weeks
Trial: 18759067
Drug: 0.625 mg
RxNorm normalized name: estrone 0.625 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.625 mg estrogen + 5 mg medroxyprogesterone acetate/day and 15 mg/day zinc sulfate for 2 weeks
Trial: 27110636
Drug: Non-treatment-seeking comparison
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-treatment-seeking comparison group
Trial: 24407920
Drug: Ezetimibe (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ezetimibe (10 mg/day) for 6 months
Trial: 21842174
Drug: Low molecular
RxNorm normalized name: Low molecular weight heparin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low molecular weight heparin (Bemiparin)
Trial: 21842174
Drug: Low dose
RxNorm normalized name: Low Dose ASA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dose aspirin (LDA)
Trial: 10333390
Drug: Amnioinfusion (normal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amnioinfusion (normal saline at room temperature infused at 10 mL/min for 60 min, then 3 mL/min until delivery)
Trial: 10333390
Drug: Control (antibiotics
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (antibiotics and acetaminophen without amnioinfusion)
Trial: 7695166
Drug: Pravastatin therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pravastatin therapy started one month before PTCA
Trial: 7654891
Drug: Ranitidine 150
RxNorm normalized name: ranitidine 150 MG
DrugBank: Ranitidine (DB00863)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ranitidine 150 mg daily
Trial: 2262119
Drug: Ranitidine 300
RxNorm normalized name: ranitidine 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ranitidine 300 mg for attacks
Trial: 6892812
Drug: Epidural morphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epidural morphine injections (2-3 mg in 10 cc saline solution 0.9%)
Trial: 28864688
Drug: Propofol plus
RxNorm normalized name: Propofol
DrugBank: Propofol (DB00818)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Propofol plus 0.5-0.8 μg/kg fentanyl
Trial: 28864688
Drug: Propofol plus
RxNorm normalized name: Propofol
DrugBank: Propofol (DB00818)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Propofol plus 0.05-0.08 μg/kg sufentanil
Trial: 28864688
Drug: Propofol plus
RxNorm normalized name: Propofol
DrugBank: Propofol (DB00818)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Propofol plus 0.04-0.05 mg/kg dezocine
Trial: 28864688
Drug: Propofol plus
RxNorm normalized name: Propofol
DrugBank: Propofol (DB00818)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Propofol plus 0.04-0.05 mg/kg oxycodone
Trial: 28864688
Drug: Propofol (2.4-3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propofol (2.4-3 mg/kg) plus 2-2.5 mL saline
Trial: 25365866
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of Cycloferon 5% liniment and Polyoxidonium with MetrogilDenta gel
Trial: 25365866
Drug: MetrogilDenta gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MetrogilDenta gel
Trial: 17233817
Drug: Observation (as
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Observation (as maintenance therapy)
Trial: 14766686
Drug: Remifentanil (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Remifentanil (5 microg.kg(‐1).hr(‐1) infusion, 25 microg boli, refractory period of five minutes)
Trial: 14766686
Drug: Propofol (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propofol (2 mg.kg(‐1).hr(‐1) infusion, 0.5 mg.kg(‐1) boli, refractory period of ten minutes)
Trial: 11942868
Drug: Intramuscular ketoprofen
RxNorm normalized name: Ketoprofen
DrugBank: Ketoprofen (DB01009)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intramuscular ketoprofen
Trial: 162675
Drug: Isoxsuprine 10
RxNorm normalized name: isoxsuprine 10 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Isoxsuprine 10 mg, acetaminophen 250 mg, caffeine 30 mg
Trial: 31429790
Drug: Yi-Zhi-An-Shen granules
RxNorm normalized name: Aldex AN
DrugBank: Doxylamine (DB00366)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Yi-Zhi-An-Shen granules (YZASG) administered three times a day for 16 weeks
Trial: 31429790
Drug: Placebo administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo administered three times a day for 16 weeks
Trial: 24673165
Drug: 40 mg
RxNorm normalized name: rutin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 mg of oral zinc sulphate tablets for 14 days
Trial: 21048508
Drug: Latanoprost-timolol-fixed combination
RxNorm normalized name: latanoprost / timolol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Latanoprost-timolol-fixed combination (LTFC)
Trial: 19636660
Drug: Bupivacaine (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bupivacaine (5 mg)
Trial: 19636660
Drug: Neosaxitoxin (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neosaxitoxin (10 microg) plus Bupivacaine (5 mg)
Trial: 9216352
Drug: Combined medical
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined medical and cognitive-behavioral treatment
Trial: 31528769
Drug: Intralesional triamcinolone
RxNorm normalized name: Triamcinolone
DrugBank: Triamcinolone (DB00620)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intralesional triamcinolone acetonide (TA) injection
Trial: 29040223
Drug: Losartan (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Losartan (100 mg·d)
Trial: 25445081
Drug: Social Effectiveness
RxNorm normalized name: Safety 1st Social Safety Pack KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Social Effectiveness Therapy (SET)
Trial: 17872493
Drug: Mepolizumab 250
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mepolizumab 250 mg
Trial: 17872493
Drug: Mepolizumab 750
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mepolizumab 750 mg
Trial: 555600
Drug: Pirbuterol 15
RxNorm normalized name: pirbuterol 15 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pirbuterol 15 mg
Trial: 19514
Drug: Metaproterenol 20
RxNorm normalized name: metaproterenol 20 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metaproterenol 20 mg
Trial: 555600
Drug: Pirbuterol 10
RxNorm normalized name: pirbuterol 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pirbuterol 10 mg
Trial: 25914334
Drug: Trigonella foenum‐graecum
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trigonella foenum‐graecum seed extract (libifem) at a dose of 600 mg/day
Trial: 24096616
Drug: Amlodipine/losartan 5/50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amlodipine/losartan 5/50 mg or 5/100 mg
Trial: 9390667
Drug: Acetazolamide (ACZ)
RxNorm normalized name: Acetazolamide
DrugBank: Acetazolamide (DB00819)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Acetazolamide (ACZ) - 3 oral doses (14, 8, and 2 hours prior to testing)
Trial: 26387039
Drug: Gefitinib monotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gefitinib monotherapy (250 mg/body) for 8 weeks followed by cisplatin and docetaxel (40 mg/m2) on days 1, 8, 29, and 36, and concurrent 3‐dimensional conformal thoracic radiotherapy (2 Gy daily for 5 days a week to a total of 60 Gy)
Trial: 26387039
Drug: Cisplatin and
RxNorm normalized name: A micelle drug formulation composed of cisplatin and mPEG-poly(l-Glu) diblock copolymer with 1,3-propanediyl linkagecisplatin is incorporated in polymeric micelles via polymer-metal complex formation with cis-geometry of PT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cisplatin and docetaxel (40 mg/m2) on days 1, 8, 29, and 36, and concurrent 3‐dimensional conformal thoracic radiotherapy (2 Gy daily for 5 days a week to a total of 60 Gy)
Trial: 15317320
Drug: Benzylpenicilloyl-polylysine (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Benzylpenicilloyl-polylysine (5 mg/mL)
Trial: 15317320
Drug: PrePen (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PrePen (5 mg/mL)
Trial: 9013058
Drug: four-pellet group
RxNorm normalized name: Four-Way
FDA approved: no
EMA approved: no
PMDA approved: no
Description: four-pellet group (174 mg NET)
Trial: 9013058
Drug: five-pellet group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: five-pellet group (266.5 mg NET)
Trial: 7875749
Drug: Diclofenac sodium
RxNorm normalized name: Diclofenac Sodium
DrugBank: Diclofenac (DB00586)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Diclofenac sodium (preoperative administration)
Trial: 7875749
Drug: Diclofenac sodium
RxNorm normalized name: Diclofenac Sodium
DrugBank: Diclofenac (DB00586)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Diclofenac sodium (postoperative administration)
Trial: 3220958
Drug: Hypnotic 'imaginative
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hypnotic 'imaginative involvement'
Trial: 3220958
Drug: All treatment
RxNorm normalized name: UNDECYLENIC ACID 8 g in 30 mL / TOLNAFTATE 1 g in 30 mL TOPICAL LIQUID [Fugal nall treatment]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: All treatment groups (Hypnotic, Distraction, Control)
Trial: 21938543
Drug: Salsalate (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Salsalate (3 g/day)
Trial: 18301136
Drug: Initially conservative
RxNorm normalized name: brigatinib
DrugBank: Brigatinib (DB12267)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Initially conservative approach (optimal medical therapy with coronary angiography in selected cases with refractory ischemia)
Trial: 10731276
Drug: 3 doses
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: 3 doses of beta-radiation (28, 35, and 42 Gy)
Trial: 1585349
Drug: Intraoperative radiation
RxNorm normalized name: allantoin
DrugBank: Allantoin (DB11100)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intraoperative radiation therapy combined with hyperthermia
Trial: 1585349
Drug: Intraoperative radiation
RxNorm normalized name: allantoin
DrugBank: Allantoin (DB11100)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intraoperative radiation therapy without hyperthermia (control group)
Trial: 2986474
Drug: magnesium trisilicate
RxNorm normalized name: Magnesium Trisilicate
DrugBank: Magnesium trisilicate (DB09281)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: magnesium trisilicate mixture (BP) 30 ml
Trial: 2986474
Drug: metoclopramide 10
RxNorm normalized name: metoclopramide 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: metoclopramide 10 mg intramuscularly
Trial: 2986474
Drug: ranitidine 150
RxNorm normalized name: ranitidine 150 MG
DrugBank: Ranitidine (DB00863)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: ranitidine 150 mg orally on the night prior to, and the morning of, surgery
Trial: 2986474
Drug: metoclopramide 10
RxNorm normalized name: metoclopramide 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: metoclopramide 10 mg intramuscularly in combination with oral ranitidine 150 mg
Trial: 22868657
Drug: no medication
FDA approved: no
EMA approved: no
PMDA approved: no
Description: no medication
Trial: 30727947
Drug: Occupational therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Occupational therapy (OT) with 8 extra home sessions over 4 supplementary months
Trial: 22594985
Drug: Photodynamic therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Photodynamic therapy (ALA, 630-635 nm wavelength)
Trial: 17396436
Drug: Behavior modification
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Behavior modification intervention (half-hour talk on exercise and diet, repeated after 3 months, weekly diaries, weekly phone calls)
Trial: 14557419
Drug: Combined T(4)/T(3)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined T(4)/T(3) treatment (liothyronine 10 micro g substituted for 50 micro g of T(4))
Trial: 14557419
Drug: Combined T(4)/T(3)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined T(4)/T(3) treatment
Trial: 14557419
Drug: T(4) treatment
RxNorm normalized name: 4-T-BUTYLCYCLOHEXANOL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: T(4) treatment
Trial: 8762789
Drug: One injection
RxNorm normalized name: naloxone Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: One injection of penicillin G
Trial: 8762789
Drug: Penicillin V
RxNorm normalized name: Penicillin V
DrugBank: Phenoxymethylpenicillin (DB00417)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Penicillin V tablets for 6 days
Trial: 30336852
Drug: Intraoperative ketamine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intraoperative ketamine (0.5 mg kg-1 or 1.0 mg kg-1)
Trial: 21337906
Drug: Local conjunctival
RxNorm normalized name: Sus scrofa conjunctiva preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Local conjunctival immunotherapy (LCIT) using mixed Dermatophagoides extracts, administered as eyedrops once daily for 6 months.
Trial: 21337906
Drug: Balanced salt
RxNorm normalized name: Balanced Salt Solution
DrugBank: Magnesium chloride (DB09407)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Balanced salt solution (BSS) as a control for 6 months.
Trial: 18683852
Drug: Bacopa monniera
RxNorm normalized name: Bacopa monniera leaf
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bacopa monniera (2 x 150 mg KeenMind)
Trial: 16437190
Drug: Calcium, vitamin
RxNorm normalized name: Vitamin B1 with Calcium, Vitamin B1 with Calcium oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcium, vitamin D, and sex steroids (without pamidronate)
Trial: 12798977
Drug: D-fenfluramine (D-FEN)
RxNorm normalized name: fenfluramine
DrugBank: Fenfluramine (DB00574)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: D-fenfluramine (D-FEN) (0.5 mg/kg)
Trial: 17290328
Drug: Cytokine therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cytokine therapy
Trial: 8868976
Drug: Saline solution
RxNorm normalized name: Unisol 4 Saline Solution
DrugBank: Sodium chloride (DB09153)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Saline solution as placebo (control group, n = 22)
Trial: 21551161
Drug: Bisoprolol (target
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bisoprolol (target dose 10 mg o.d.)
Trial: 21551161
Drug: Enalapril (target
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enalapril (target dose 10 mg b.i.d.)
Trial: 21551161
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of bisoprolol and enalapril
Trial: 20684146
Drug: 15% azelaic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15% azelaic acid gel applied twice daily for one month
Trial: 20684146
Drug: Placebo gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo gel applied twice daily for one month
Trial: 16359967
Drug: Flutamide (250
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flutamide (250 mg/d for the first 10 days of the cycle)
Trial: 16359967
Drug: Spironolactone plus
RxNorm normalized name: Spironolactone Plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Spironolactone plus Diane 35 (spironolactone 100 mg/d; Diane 35 is a combination tablet of 2 mg cyproterone acetate and 35 microg ethinylestradiol/d for 9 months)
Trial: 12225339
Drug: Diethylstilboestrol (DES)
RxNorm normalized name: Diethylstilbestrol
DrugBank: Diethylstilbestrol (DB00255)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Diethylstilboestrol (DES) and aspirin
Trial: 9706950
Drug: Fentanyl (0.35
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fentanyl (0.35 mg)
Trial: 3044181
Drug: Nalbuphine (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nalbuphine (20 mg)
Trial: 15692543
Drug: Ketoprofen (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketoprofen (100 mg)
Trial: 9706950
Drug: 0.9% Sodium
RxNorm normalized name: LMD with 0.9% Sodium Chloride
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.9% Sodium Chloride (10 mL)
Trial: 7832598
Drug: Intravenous magnesium
RxNorm normalized name: immunoglobulins, intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous magnesium sulfate (2 g)
Trial: 2226737
Drug: Palliative treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Palliative treatment regimens
Trial: 27607850
Drug: Nurse-initiated recall
RxNorm normalized name: brigatinib
DrugBank: Brigatinib (DB12267)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Nurse-initiated recall cards and medication chart checking at handover
Trial: 23111657
Drug: Intravenous peramivir
RxNorm normalized name: Peramivir
DrugBank: Peramivir (DB06614)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Intravenous peramivir 400 mg once daily
Trial: 23111657
Drug: Intravenous peramivir
RxNorm normalized name: Peramivir
DrugBank: Peramivir (DB06614)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Intravenous peramivir 200 mg once daily
Trial: 23111657
Drug: Oral oseltamivir
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral oseltamivir 75 mg twice daily
Trial: 23111657
Drug: Intravenous peramivir
RxNorm normalized name: Peramivir
DrugBank: Peramivir (DB06614)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Intravenous peramivir 400 mg once daily (in clinically unstable patients)